Neurevolution Medicine, LLC
Richard D. Batson is the executive director and co-founder of Neurevolution Medicine, LLC. His clinical practice focuses on traumatic brain injury evaluation and rehabilitation, male hormonal health, attention deficits, and cognitive decline.
Dr. Batson’s postgraduate dissertation is in the area of post-traumatic hypopituitarism (PTHP), a medical condition that evolves in some individuals following traumatic brain injury and results in hormonal/endocrine dysfunction. He works clinically with the TBI population with a focus on evaluation and treatment of PTHP. In addition to his clinical practice, Dr. Batson provides forensic consulting services for traumatic brain injury cases involving civil litigation and is sought after by legal experts for consultation regarding PTHP. He has served as an expert consultant and/or expert witness in over one hundred traumatic brain injury cases. He currently manages multi-disciplinary forensic evaluations across the fields of endocrinology, neurology, neuroradiology and neuropsychology. He also works in collaboration with doctors in the fields of sleep medicine, neuropsychiatry and neuro-optometry, particularly with respect to traumatic brain injury related sleep, psychiatric and visual disorders.
He has generated a number of publications and academic papers including on topics related to post-traumatic hypopituitarism (PTHP), selection criteria and eligibility for growth hormone replacement in patients with hypopituitarism, the management of hypogonadotropic hypogonadism in type 2 diabetes mellitus and obesity, a review of triiodothyronine (T3) therapy in hypothyroidism, the diagnosis and management of primary hyperaldosteronism, guidelines for the diagnosis and management of polycystic ovary syndrome, bidirectional and tandem actions of aldosterone and parathyroid hormone with implications for cardiovascular, bone and metabolic disease risk and prevention, and management of fragility fractures in the age male in endocrinology practice. He has also conducted literature reviews in the areas of psychotic disorders following traumatic brain injury, hypogonadotropic hypogonadism following traumatic brain injury, and a review of the cosyntropin stimulation test in secondary adrenal insufficiency diagnosis. Most recently, he served as a content expert for a Cochrane Systematic Review on biofeedback and IBS and co-authored a chapter on the comprehensive treatment of osteoarthritis published in Metabolic Therapies in Orthopedics recently featured in the Hopkins Reader, Johns Hopkins Medicine. He is the recipient of the 2012 Natural Standard Research Collaboration Award for excellence in multidisciplinary, evidence-based research practices, healthcare communications and information. Natural Standard is an international research collaboration that systematically reviews scientific evidence on complementary and alternative medicine (CAM) and together with the faculty of Harvard Medical School, Natural Standard provides consumer information on CAM for Harvard Health Publications. In addition, he is an invited peer-reviewer for the Journal of Alzheimer's Disease.
He is one of the only licensed naturopathic physicians in the United States with formal university training and mentorship in conventional endocrinology and is a diplomate in endocrinology with distinction. His endocrine clinical practice focuses on evaluating and managing select endocrine conditions including hypopituitarism, hypothyroidism, male and female hypogonadism, and polycystic ovarian syndrome, as well a screening for a variety of endocrine conditions with referral/coordinated care involving generalists and specialists in the fields of endocrinology and neuroendocrinology.
1300 114th Avenue Southeast Suite 106, Bellevue, Washington 98004, United States
ND, ABAAHP, Dipl.
Bastyr University, Seattle
Neurevolution Medicine, LLC
ADHD, Anxiety, Depression, Memory improvement, Traumatic brain injury, PTSD, traumatic brain injury evaluation and rehabilitation, male hormonal health, attention deficits, and cognitive decline.